PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice

Journal of Clinical Investigation

Volumn 107, Issue 8, 2001, Pages 1025-1034

  Tordjman, K ^a   Bernal Mizrachi, C ^a   Zemany, L ^a   Weng, S ^a   Feng, C ^a   Zhang, F ^a   Leone, T C ^a   Coleman, T ^a   Kelly, D P ^a   Semenkovich, C F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR; CD36 ANTIGEN; CELL RECEPTOR; GLUCOSE; LIPOPROTEIN; LIPOPROTEIN LIPASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PIRINIXIC ACID; PYRIMIDINE DERIVATIVE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CONTROLLED STUDY; GLUCONEOGENESIS; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID DIET; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THORACIC AORTA; ANIMAL; AORTA; ARTERIOSCLEROSIS; C57BL MOUSE; FAT INTAKE; FEMALE; GENE EXPRESSION; GENETICS; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD36; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOOD PRESSURE; CHEMOKINE CCL2; DIETARY FATS; FEMALE; GENE EXPRESSION; GLUCOSE; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; LIPOPROTEINS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0034744590     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI11497     Document Type: Article

References (53)

1. Insulin sensitivity and atherosclerosis
2. Roles of PPARs in health and disease
3. Peroxisome proliferator activated receptor-α expression in human liver
4. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPAR-α, -β, and -γ in the adult rat
5. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliforator-activated receptors
6. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism of insulin resistance
7. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
8. PPARα and PPARγ activators direct a tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
9. PPARγ promotes monocyte/macrophage differentiation and update of oxidized LDL
10. Identification of a functional peroxisome proliforator-activated responsive element in the m urine fatty acid transport protein gene
11. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter
12. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice
13. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
14. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
15. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
16. Peroxisomal proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
17. Altered nuclear protein binding to the first intron of the renin gene of the spontaneously hypertensive rat
18. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
19. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging
20. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity
21. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
22. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption
23. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice
24. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes
25. Regulation of guinea pig very low density lipoprotein secretion rates by dietary far saturation
26. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity
27. Exercise induces human lipoprotein lipase gene expression in skeletal muscle but not adipose tissue
28. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice
29. Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency: Islet LPL regulates insulin secretion
30. Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis
31. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects
32. Molecular scanning of the human PPARα gene: Association of-the L162V mutation with hyperapobetalipoproteinemia
33. The human peroxisome proliferator-activated receptor alpha gene: Identification and functional characterization of two natural allelic variants
34. Fibrinogen deficiency is compatible with the development of atherosclerosis in mice
35. Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1
36. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
37. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice
38. Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
39. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis
40. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
41. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice
42. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment
43. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo
44. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo
45. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in LDL receptor deficient mice
46. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis
47. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
48. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
49. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice
50. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
51. Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus
52. Control mechanisms of gluconeogenesis and ketogenesis. I. Effects of oleate on gluconeogenesis in perfused rat liver
53. Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activity by NADH oxidase and SOD